Sign in
TerminatedNo phase

Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders

Key facts

Who runs it
Baylor Research Institute
Where
Dallas, United StatesSee the site
Trial code
Status
Terminated
People taking part
42 people enrolled
Started
Jun 2014
Ended
Oct 2024
Type of study
Interventional
Treatments tested
  • POEM
Record updated
20 March 2025
Why it stopped
The study was terminated by the Principal Investigator's to redesign it using more efficient processes.

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Patient with symptomatic achalasia or EGJ outflow obstruction with a motility study, esophagram, and EGD consistent with EGJ outflow obstruction
  • Medical indication for surgical myotomy
  • Ability to undergo general anesthesia
  • Age > 18 yrs. of age and <85 yrs. of age with ability to give informed consent
  • Candidate for laparoscopic esophageal myotomy

Who cannot take part

  • Previous chest radiotherapy
  • Malignant or premalignant esophageal lesion
  • Eosinophilic esophagitis
  • Barrett's esophagus
  • Stricture of esophagus
  • Contraindications for EGD
  • Unable to provide informed consent
  • Pregnancy

Where in United States

  • Baylor University Medical CenterDallas, United States

About the trial

What the trial wants to find out

The purpose of this study is to show that the Per-Oral Endoscopic Myotomy (POEM) procedure is an effective treatment for people with achalasia.

The group in the trial

  • POEM procedureTreatment being tested

    Patients who underwent POEM

    Treatment: POEM

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Evaluation of Per-Oral Endoscopic Myotomy (POEM) of the Lower Esophageal Sphincter for the Treatment of Esophageal Swallowing Disorders
Record updated
20 March 2025